Cargando…
Dexmedetomidine prevents cardiomyocytes from hypoxia/reoxygenation injury via modulating tetmethylcytosine dioxygenase 1-mediated DNA demethylation of Sirtuin1
Myocardial hypoxia/reoxygenation (H/R) injury is a common pathological change in patients with acute myocardial infarction undergoing reperfusion therapy. Dexmedetomidine (DEX) has been found to substantially improve ischemia-mediated cell damage. Here, we focus on probing the role and mechanism of...
Autores principales: | Wang, Li, Wang, Shaowei, Jia, Tong, Sun, Xiaojia, Xing, Zhen, Liu, Hui, Yao, Jie, Chen, Yanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161963/ https://www.ncbi.nlm.nih.gov/pubmed/35387565 http://dx.doi.org/10.1080/21655979.2022.2054762 |
Ejemplares similares
-
Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes
por: Peng, Ke, et al.
Publicado: (2017) -
Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms
por: Cai, Shunv, et al.
Publicado: (2021) -
Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway
por: Shi, Xiaoqiao, et al.
Publicado: (2020) -
Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy
por: Yang, Mao, et al.
Publicado: (2022) -
HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes
por: Chen, Dongling, et al.
Publicado: (2016)